Remicade [infliximab] Therapy in Psoriatic Arthritis: Investigation of Real Life Regimen in Austria Over 9 Consecutive Infusions.
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck & Co; Schering-Plough
- 08 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 23 Aug 2008 New trial record.